PROLOR Biotech, Inc. (PBTH)
-NYSE MKT 6.44 
0.03(0.47%) 4:02PM EDT
| Prev Close: | 6.41 |
|---|
| Open: | 6.50 |
|---|
| Bid: | 6.20 x 100 |
|---|
| Ask: | 6.68 x 200 |
|---|
| 1y Target Est: | 9.00 |
|---|
| Beta: | 0.1 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 6.40 - 6.55 |
|---|
| 52wk Range: | 4.25 - 6.56 |
|---|
| Volume: | 170,007 |
|---|
| Avg Vol (3m): | 283,416 |
|---|
| Market Cap: | 410.10M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.29 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- PBTH July Options Begin Tradingat TheStreet(Mon, May 20)
- PROLOR BIOTECH, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- PROLOR BIOTECH, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buyat Seeking Alpha(Tue, May 7)
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection With the Sale of the Company to OPKO Health, Inc.GlobeNewswire(Thu, May 2)
- Opko's Next Acquisition?at Seeking Alpha(Thu, May 2)
- A Sweeter Deal On The Horizon For Prolor Biotech?at Seeking Alpha(Wed, May 1)
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.PR Newswire(Mon, Apr 29)
- PROLOR BIOTECH, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Mon, Apr 29)
- Lifshitz Law Firm Announces Investigation of Buckeye Technologies Inc., Intuitive Surgical, Inc., MPG Office Trust, Inc., and PROLOR Biotech, Inc.PR Newswire(Sun, Apr 28)
- Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.Business Wire(Sat, Apr 27)
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.Business Wire(Fri, Apr 26)
- PROLOR Biotech, Inc. Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Acquisition AgreementBusiness Wire(Fri, Apr 26)
- Law Firm Brower Piven Announces Investigation of PROLOR Biotech, Inc. Proposed BuyoutBusiness Wire(Fri, Apr 26)
- Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. BuyoutBusiness Wire(Thu, Apr 25)
Press Releases
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection With the Sale of the Company to OPKO Health, Inc.GlobeNewswire(Thu, May 2)
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.PR Newswire(Mon, Apr 29)
- Lifshitz Law Firm Announces Investigation of Buckeye Technologies Inc., Intuitive Surgical, Inc., MPG Office Trust, Inc., and PROLOR Biotech, Inc.PR Newswire(Sun, Apr 28)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.38 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.09 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
PROLOR Biotech, Inc., a development stage biopharmaceutical company, engages in the development of proprietary versions of already-approved therapeutic proteins.
View More